PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 88831981 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 112 |
MARK SECTION | |
MARK | VIVJOA (see, http://uspto.report/TM/88831981/mark.png) |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | VIVJOA |
OWNER SECTION (current) | |
NAME | Mycovia Pharmaceuticals, Inc. |
MAILING ADDRESS | 4505 Emperor Blvd., Suite 300 |
CITY | Durham |
STATE | North Carolina |
ZIP/POSTAL CODE | 27703 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
OWNER SECTION (proposed) | |
NAME | Mycovia Pharmaceuticals, Inc. |
MAILING ADDRESS | 4505 Emperor Blvd., Suite 300 |
CITY | Durham |
STATE | North Carolina |
ZIP/POSTAL CODE | 27703 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | Devon E. White |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | ip@wyrick.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Devon E. White |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | ip@wyrick.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
DOCKET/REFERENCE NUMBER | 029850.018 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 005 |
CURRENT IDENTIFICATION | Pharmaceutical preparations and substances for the treatment and/or prevention of fungal and parasitic infections; Pharmaceutical preparations and substances for the prevention and/or treatment of mucosal, invasive, and superficial fungal infections, including those caused by candida and dermatophyte species; Pharmaceutical preparations and substances for the prevention and/or treatment of endemic fungal diseases or infections; Pharmaceutical preparations for the treatment and prevention of skin conditions; Pharmaceutical preparations, namely, gels, creams, sprays or other topical preparations treatment of skin conditions; Intravenous pharmaceutical preparations for the treatment and prevention of invasive fungal infections |
GOODS OR SERVICES | KEEP ALL LISTED |
EXTENSION SECTION | |
EXTENSION NUMBER | 2 |
ONGOING EFFORT | product or service research or development |
ALLOWANCE MAIL DATE | 09/08/2020 |
STATEMENT OF USE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES | 1 |
SUBTOTAL AMOUNT [EXTENSION FEE] | 125 |
TOTAL AMOUNT | 125 |
SIGNATURE SECTION | |
SIGNATURE | /dew/ |
SIGNATORY'S NAME | Devon E. White |
SIGNATORY'S POSITION | Attorney of Record |
DATE SIGNED | 08/18/2021 |
SIGNATORY'S PHONE NUMBER | 9197814000 |
SIGNATURE METHOD | Sent to third party for signature |
FILING INFORMATION | |
SUBMIT DATE | Wed Aug 18 14:12:41 ET 2021 |
TEAS STAMP | USPTO/ESU-XX.XXX.XXX.XXX- 20210818141241177165-8883 1981-781c2fcce1d0b5ddc12a 57b8adb3104c3cba1d4caf246 e543a13e22b1d6471c-CC-123 83358-2021081813274152469 3 |
PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |